Yandong
Xie
a,
Xueying
Lu
b,
Zhen
Wang
a,
Mingxi
Liu
a,
Liang
Liu
a,
Ran
Wang
a,
Kun
Yang
a,
Hong
Xiao
c,
Jianyong
Li
*b,
Xianglong
Tang
*ac and
Hongyi
Liu
*a
aDepartment of Neurosurgery, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing 210029, China. E-mail: hyliu18@njmu.edu.cn; xltang0326@163.com
bDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing 210029, China. E-mail: lijianyonglm@126.com
cDepartment of Neuro-Psychiatric Institute, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing 210029, China
First published on 29th May 2024
Expression of concern for ‘A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma’ by Yandong Xie, et al., Biomater. Sci., 2022, 10, 6791–6803, https://doi.org/10.1039/D2BM01145J.
An independent expert has assessed the Fig. 5 and is concerned the authors have not provided an accurate representation of the experiments that were conducted.
An Expression of Concern will continue to be associated with the article until our investigation is concluded and we receive conclusive evidence regarding the reliability of the reported data.
Signed: Maria Southall
Date: 14/05/2024
Executive Editor, Biomaterials Science
This journal is © The Royal Society of Chemistry 2024 |